Tumor NGS is performed, and patients with a predicted deleterious alteration in ERCC2 (or any of 8 other DNA repair genes) who experience a complete clinical response following GC are able to forego standard-of-care radical cystectomy and instead undergo close surveillance with imaging and cystoscopy. Here, ERCC2 is linked to neoplasm.